SEC Filing Analysis: Performant Healthcare Inc (PHLT)

Executive Summary

• Trading Significance: High
• Key Takeaway: Performant Healthcare's CEO, Simeon Kohl, disposed of his entire holding in the company, valued at over $11.5 million, as a direct result of the company's merger agreement.
• Market Impact: Neutral. This transaction is a contractual obligation tied to a pre-announced acquisition at a fixed price ($7.75 per share) and does not signal new information about the company's future prospects.

Company Information

Field	Value
Company	Performant Healthcare Inc
Ticker Symbol	PHLT
CIK	0001550695
Industry	Services-Miscellaneous Business Services

Insider Information

Field	Value
Name	Kohl Simeon
CIK	0001703807
Title/Position	Chief Executive Officer
Relationship	Director, Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-21
Transaction Code	D (Disposition)
Security Type	Common Stock and Restricted Stock Units
Shares Involved	1,490,142
Price Per Share	$7.75
Total Value	$11,548,600.50
Shares Owned After	0
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$11,548,600.50
% of Market Cap	1.89%
Shares Transacted	1,490,142
% of Shares Outstanding	1.85%
Post-Transaction Ownership	0 shares (0.00% of outstanding)
Materiality Assessment	Highly Significant

Impact Evaluation

• Market Cap Context: The $11.5 million disposition is highly material, representing 1.89% of Performant Healthcare's $610 million market capitalization.
• Ownership Concentration: The transaction reduces the CEO's ownership from approximately 1.85% of outstanding shares to zero, marking a complete exit from the company, as expected in a cash-out merger.
• Dilution Impact: Not applicable, as this is a disposition of existing shares and equity awards, not an issuance of new equity.
• Transaction Significance: The significance is driven by the large absolute value and its high percentage relative to both market cap and shares outstanding. It confirms the finality of the merger and the cash-out for key executives.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This disposition is a mechanical step in the completion of a previously announced merger. The market has already priced in the acquisition at the $7.75 per share consideration. This filing provides confirmation rather than new market-moving information.

Volume & Sentiment

• Expected Volume Impact: The filing itself will not drive volume, but the underlying merger event leads to the delisting of the stock.
• Sentiment Indicator: Neutral. The action is procedural and aligns with the terms of the acquisition by Continental Buyer, Inc.

Investment Insights

Positive Market Indicators

• The filing confirms that the merger is proceeding as planned, providing certainty for shareholders awaiting the cash payout.

Risk Factors

• For public shareholders, this event marks the end of their investment in Performant Healthcare, as the company will become a wholly-owned subsidiary of Continental Buyer, Inc. and will no longer be publicly traded.

Key Takeaways

1. Complete Executive Exit: CEO Simeon Kohl has liquidated his entire position in the company for $11.5 million.
2. Merger-Driven Transaction: This is not a discretionary sale but a mandatory disposition required by the terms of the company's acquisition.
3. Highly Material Event: The transaction's size, at 1.89% of the company's market cap, underscores the scale of the change-of-control event.

Additional Context

Transaction Notes

• Special Circumstances: As detailed in the filing's footnotes, all of the CEO's common stock, time-based restricted stock units (RSUs), and performance-based restricted stock units (PRSUs) were automatically canceled and converted into the right to receive a cash payment of $7.75 per share, effective immediately prior to the merger's completion.